This content is machine translated Secondary prevention after ACS: individually optimized lipid management Trend towards early combination therapy and new strategies for lowering Lp(a) Secondary prevention after an acute coronary syndrome (ACS) is crucial for improving quality of life and reducing morbidity and mortality rates. Elevated blood lipid levels such as LDL cholesterol and...…
View Post 13 min This content is machine translated Why lipoprotein(a) is the biggest therapeutic vacuum in cardiology Lp(a): The underestimated risk factor before the turning point One in five people worldwide has a genetically elevated lipoprotein(a) – and knows nothing about it. Unlike LDL cholesterol, this independent, causally significant risk factor cannot be significantly influenced by...…
